Drug Trial Radar · NCT05857267
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
Last checked: Nov 20, 2026Latest source record: Nov 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Mar 7, 2023
Primary completion
Nov 4, 2024
Study completion Nov 4, 2024
Sponsor
- Lead sponsor
- Laboratorios PoenIndustry
- Sponsor type
- Industry
- First posted
- May 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate the tolerability of the new formulation of Dorzolamide+Timolol preservative free developed in OSD Aptar Pharma multidose system in comparison with Dorzolamide +Timolol BAK preserved ophthalmic formulation.
Conditions
- Glaucoma, Open-Angle
- Ocular Hypertension
Interventions
Dorzolamide / Timolol Ophthalmic SolutionDrug
Dorzolamide-timolol fixed combination in a preservative-free multidose device
dorzolamide/timololDrug
Dorzolamide-timolol BAK-preserved fixed combination
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular Surface Disease SymptomsTime frame: Change from baseline in OSDI score at 24 weeks
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Consultorios de Oftalmología
Buenos Aires, Argentina
Clínica de Ojos Dr. Nano
Olivos, Buenos Aires, Argentina
Consultorio Dr. Peyret
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
Gonella Oftalmólogos
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
Centro Diagnóstico Dr. Gentile
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina
Centro oftalmológico Dr. Casiraghi & asociados
Ciudad Autónoma de Buenos Aire, Buenos Aires F.D., Argentina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.